Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

His time at Pfizer has coincided with the spectacular success of its BioNTech-partnered mRNA vaccine for COVID-19 – Comirnaty – and as GSK itself struggled to make headway with its own ...

GSK and Pfizer’s full-year financial results show that the former is currently winning the battle for take-up of their rival respiratory syncytial virus (RSV) vaccines, although, there are signs ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Cura Health, a leading provider in Kuwait's pharmaceutical and healthcare sector, today hosted a wellness event for its ...

MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Investors would want to prepare for rotating out of the seven - Apple (AAPL), Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN), Nvidia (NVDA), Meta (META), and Tesla (TSLA). In exchange, they ...

TV18’s Shereen Bhan at Davos 2025, Adar Poonawalla, CEO of the Serum Institute of India, emphasised the need for balanced reforms that maintain affordability while enabling companies to generate ...